A detailed history of First Trust Advisors LP transactions in Innoviva, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 234,617 shares of INVA stock, worth $4.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
234,617
Previous 278,056 15.62%
Holding current value
$4.19 Million
Previous $4.56 Million 0.7%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$16.33 - $20.04 $709,358 - $870,517
-43,439 Reduced 15.62%
234,617 $4.53 Million
Q2 2024

Aug 13, 2024

BUY
$14.4 - $16.4 $4 Million - $4.56 Million
278,056 New
278,056 $4.56 Million
Q3 2023

Nov 13, 2023

BUY
$12.37 - $13.89 $712,920 - $800,522
57,633 New
57,633 $748,000
Q2 2022

Aug 12, 2022

SELL
$14.32 - $19.88 $525,415 - $729,417
-36,691 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$15.39 - $20.25 $564,674 - $742,992
36,691 New
36,691 $710,000
Q4 2021

Feb 08, 2022

SELL
$15.91 - $18.72 $5.56 Million - $6.54 Million
-349,317 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$13.06 - $17.24 $1.21 Million - $1.6 Million
-93,016 Reduced 21.03%
349,317 $5.84 Million
Q2 2021

Aug 16, 2021

BUY
$11.45 - $13.96 $4.55 Million - $5.55 Million
397,449 Added 885.5%
442,333 $5.93 Million
Q1 2021

May 14, 2021

BUY
$11.06 - $12.87 $101,199 - $117,760
9,150 Added 25.61%
44,884 $536,000
Q4 2020

Feb 02, 2021

SELL
$9.33 - $12.48 $484,376 - $647,911
-51,916 Reduced 59.23%
35,734 $443,000
Q3 2020

Nov 05, 2020

SELL
$10.33 - $14.49 $123,371 - $173,054
-11,943 Reduced 11.99%
87,650 $916,000
Q2 2020

Jul 22, 2020

BUY
$11.49 - $15.26 $221,963 - $294,792
19,318 Added 24.06%
99,593 $1.39 Million
Q1 2020

May 06, 2020

BUY
$8.11 - $15.23 $429,984 - $807,479
53,019 Added 194.52%
80,275 $944,000
Q4 2019

Feb 03, 2020

SELL
$10.28 - $14.38 $765,654 - $1.07 Million
-74,480 Reduced 73.21%
27,256 $386,000
Q3 2019

Nov 04, 2019

BUY
$10.05 - $14.55 $818,683 - $1.19 Million
81,461 Added 401.78%
101,736 $1.07 Million
Q2 2019

Jul 30, 2019

SELL
$13.1 - $14.95 $2.6 Million - $2.97 Million
-198,762 Reduced 90.74%
20,275 $295,000
Q1 2019

May 09, 2019

BUY
$13.69 - $20.06 $1.27 Million - $1.86 Million
92,637 Added 73.29%
219,037 $3.07 Million
Q4 2018

Feb 07, 2019

BUY
$13.96 - $18.26 $1.15 Million - $1.5 Million
82,335 Added 186.85%
126,400 $2.21 Million
Q3 2018

Oct 25, 2018

SELL
$13.63 - $15.7 $1.94 Million - $2.24 Million
-142,401 Reduced 76.37%
44,065 $672,000
Q2 2018

Aug 02, 2018

BUY
$13.44 - $17.59 $878,492 - $1.15 Million
65,364 Added 53.97%
186,466 $2.57 Million
Q1 2018

Apr 23, 2018

BUY
$13.8 - $16.99 $342,819 - $422,065
24,842 Added 25.81%
121,102 $2.02 Million
Q4 2017

Feb 08, 2018

BUY
$11.73 - $14.75 $239,632 - $301,327
20,429 Added 26.94%
96,260 $1.37 Million
Q3 2017

Oct 24, 2017

BUY
$12.06 - $14.12 $914,521 - $1.07 Million
75,831
75,831 $1.07 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.